جست‌وجوی استاد و پژوهشگر

• Terahertz Technologies
• Material Science
• Applied Physics
• +۶ مورد دیگر

Hungyen Lin is a Research Fellow at the School of Engineering, Lancaster University , specializing in terahertz technologies and their industrially relevant applications . His work bridges material science , applied physics , and engineering . Education: PhD in Electronic Engineering, University of Adelaide MSc (Research) in Computer Systems Engineering, University of South Australia BSc (1st Hons) in Computer Systems Engineering, University of Adelaide Research interests include terahertz/optical sensing for pharmaceutical film coatings , graphene and 2D materials manufacturing , fuel cells , and composites . His recent publications focus on terahertz spectroscopy for water-state analysis in membranes and industrial sensing. Scientific awards include: IEEE Senior Member Royal Academy of Engineering Industrial Fellow Higher Education Academy Fellow His projects often involve collaboration with industry partners, such as Fujitsu Siemens Computers, and academic institutions like University of Cambridge. Current students include: Daniel Baines George France Sreenivasan Kiritharan

Bülent Ahıshalıمشاهده پروفایل

استاد

• Blood-Brain Barrier (BBB) Structure and Function
• Neurodegenerative Disease Models
• Nanocarrier Drug Delivery Systems
• +۵ مورد دیگر

Prof. Dr. Bülent Ahıshalı is a distinguished academic at Koç University Faculty of Medicine , where he has served as Head of the Department of Basic Medical Sciences and Histology and Embryology since 2019. With over two decades of research focused on the structural and functional dynamics of the blood-brain barrier (BBB) , he has pioneered studies on BBB integrity in neurodegenerative diseases, inflammatory conditions, and hypertension, alongside developing nanocarrier systems for brain-targeted drug delivery. His career spans clinical electron microscopy diagnostics, academic leadership, and contributions to medical education. 1982–1989: MD, Istanbul University, Faculty of Medicine 1996: Specialization in Histology and Embryology, Istanbul University Prof. Ahıshalı’s research explores: BBB Pathophysiology under experimental and clinical pathological conditions Neurodegenerative Disease Models (e.g., Alzheimer’s, epilepsy) Nanocarrier Development for crossing the BBB Ultrastructural Diagnosis via electron microscopy 2D/3D Cell Culture in tumor biology and BBB studies His recent articles highlight trends in nanocarrier-based BBB modulation for epilepsy and sepsis, TGF-β and RhoA inhibition in hypertension, and immunoglobulin-based BBB repair . He actively contributes to academic governance and has led electron microscopy and in vitro modeling studies since the 1990s. Key professional activities include: 1998–1999: Research at Free University of Brussels (VUB) with a Turkish Education Foundation scholarship 2007: ART certification at Cerrahpaşa Faculty of Medicine Over 20 years: Electron microscopy diagnostics at Istanbul University 2012–present: Full Professor, Koç University

Ryan Seguinمشاهده پروفایل

پژوهشگر

• Pharmacotoxicology
• Drug Metabolism
• Environmental Health
• +۲ مورد دیگر

Ryan Seguin is a Researcher in the Department of Medicinal Chemistry at the University of Washington School of Pharmacy . He actively contributes to studies on benzalkonium chlorides (BACs) and quaternary ammonium compounds (QACs), focusing on their metabolic pathways, toxicity, and environmental health impacts. Collaborates with the Xu Lab on BACs' nephrotoxicity in 2D/3D human cell cultures Investigates CYP enzyme roles in BAC metabolite formation and transporter interactions Explores QACs' effects on immune function, lipid homeostasis, and neurodevelopment Email: rps87@uw.edu

Raymond R. Mattinglyمشاهده پروفایل

استاد

• Ras Signaling Pathways
• Cancer Pharmacology
• Neurofibromatosis
• +۲ مورد دیگر

Raymond R. Mattingly serves as Professor and Chair of the Department of Pharmacology & Toxicology at East Carolina University, where he leads research initiatives focused on molecular mechanisms of disease and therapeutic development. His academic leadership spans decades with significant contributions to cancer pharmacology and signal transduction research. His educational foundation includes: B.A. (Hons.) in Natural Sciences/Pharmacology from the University of Cambridge (1987) Ph.D. in Pharmacology from the University of Virginia (1993) Dr. Mattingly's research program investigates small GTPases of the Ras superfamily, particularly their roles in pathological conditions with hyperactivated Ras signaling without direct Ras mutations. His laboratory specializes in Type 1 Neurofibromatosis (NF1) and breast cancer progression, developing advanced 3D in vitro models that bridge the gap between conventional 2D cultures and animal studies. This approach enables more physiologically relevant drug screening for NF1 therapeutics and identifies molecular targets for triple-negative breast cancer and DCIS-to-invasive carcinoma transitions. Analysis of his 2018-2021 publications reveals consistent focus on tumor microenvironment dynamics, with particular emphasis on lymphatic metastasis mechanisms in triple-negative breast cancer, ERK/MAPK pathway regulation in tumor progression, and computational modeling of proteolytic processes. His work demonstrates how Rap1Gap downregulation and Sprouty4 suppression serve as molecular switches driving invasive transitions. No scientific awards were documented in the provided materials. While student advising details and grant funding specifics were not disclosed in the available documentation, his collaborative projects indicate active mentorship within cancer research teams. His laboratory maintains strong partnerships focused on mechanistic drug discovery for neurofibromatosis and breast cancer subtypes. Dr. Mattingly directs a research team developing innovative 3D culture platforms for plexiform neurofibroma and breast cancer models, with current work emphasizing tumor-lymphatic interactions and spatio-temporal proteolysis imaging. These models facilitate high-throughput drug screening while maintaining physiological relevance, addressing critical limitations in traditional preclinical cancer research.

Pedro Viana Baptistaمشاهده پروفایل

استاد

• Nanomedicine
• Nanotheranostics
• Molecular Diagnostics
• +۷ مورد دیگر

Pedro Viana Baptista serves as a Full Professor at the Faculty of Science and Technology (FCT) of Nova University of Lisbon, where he maintains an active research laboratory focused on nanomedicine and nanotheranostics. His office is located in room 308 with contact information prominently displayed, indicating his current active status at the institution. Dr. Baptista's research program centers on nanotechnology applications for molecular diagnostics and gene therapy, with particular expertise in gold and silver nanoparticles for DNA/RNA detection, mutation characterization, and cancer therapy. His work spans biosensor development for mutation detection using microfluidics platforms, nanoparticle-mediated gene delivery and silencing, and targeted drug delivery systems. The interdisciplinary nature of his research bridges nanotechnology, molecular biology, and clinical applications, with emphasis on translating laboratory findings into practical diagnostic and therapeutic approaches. Analysis of his recent publication record reveals a strong focus on cancer theranostics using nanoparticle platforms, with significant contributions to tumor-on-chip technology, KRAS mutation profiling in pancreatic cancer, miRNA detection and silencing, and 3D tumor spheroid models for drug testing. His research demonstrates consistent innovation in adapting nanotechnology for clinical applications, particularly in overcoming challenges related to drug resistance and improving cancer diagnostics. Dr. Baptista actively collaborates with numerous researchers across Portugal and internationally, as evidenced by his extensive co-authorship record. His laboratory appears to be well-integrated within the UCIBIO research unit at FCT, focusing on interdisciplinary approaches to biomedical challenges. The consistent output of high-impact publications demonstrates sustained research productivity and leadership in the nanomedicine field.

• Veterinary toxicology
• Mycotoxins
• Animal feed safety
• +۳ مورد دیگر

Lukasz Zielonka is a Professor at the University of Warmia and Mazury (UWM) within the Faculty of Veterinary Medicine, specializing in the Department of Veterinary Prevention and Feed Hygiene. With over 97 publications and an H-index of 22 (WoS/Scopus), his research bridges veterinary toxicology and computational geometry. His work investigates mycotoxin interactions in livestock, particularly zearalenone and deoxynivalenol, while also advancing 2D/3D packing algorithms. He supervises 2 doctoral students and has promoted 2 doctors, supported by project funds and advanced lab infrastructure including cell culture facilities and LC-MS detectors. Current promoter for doctoral candidates Active researcher in Veterinary Medicine and Mathematics Research Interests Zielonka's veterinary research focuses on mycotoxin effects on livestock physiology, hormone homeostasis, and intestinal health, with applications in feed safety and animal welfare. His computational work explores perfect packing problems , optimizing geometric arrangements for squares, cubes, and polygons. Recent studies combine both fields through in vivo and in vitro models alongside algorithmic innovations. Publications 2024–2025 articles highlight zearalenone's impact on human cancer patients, deoxynivalenol biodegradation via insect biomass, and mathematical breakthroughs in hypercube packing. His 15 most recent works span Veterinary Medicine, Toxicology, and Computational Geometry, reflecting interdisciplinary expertise. Laboratory Infrastructure The laboratory provides cell culture facilities, TEER meter, ELISA reader, and QQQ LC-MS for analyzing mycotoxin metabolism, hormonal changes, and tissue interactions.